학술논문
Sepsis-trained macrophages promote antitumoral tissue-resident T cells
Document Type
Article
Author
Broquet, Alexis; Gourain, Victor; Goronflot, Thomas; Le Mabecque, Virginie; Sinha, Debajyoti; Ashayeripanah, Mitra; Jacqueline, Cédric; Martin, Pierre; Davieau, Marion; Boutin, Lea; Poulain, Cecile; Martin, Florian P.; Fourgeux, Cynthia; Petrier, Melanie; Cannevet, Manon; Leclercq, Thomas; Guillonneau, Maeva; Chaumette, Tanguy; Laurent, Thomas; Harly, Christelle; Scotet, Emmanuel; Legentil, Laurent; Ferrières, Vincent; Corgnac, Stephanie; Mami-Chouaib, Fathia; Mosnier, Jean Francois; Mauduit, Nicolas; McWilliam, Hamish E. G.; Villadangos, Jose A.; Gourraud, Pierre Antoine; Asehnoune, Karim; Poschmann, Jeremie; Roquilly, Antoine
Source
Nature Immunology; 20240101, Issue: Preprints p1-18, 18p
Subject
Language
ISSN
15292908; 15292916
Abstract
Sepsis induces immune alterations, which last for months after the resolution of illness. The effect of this immunological reprogramming on the risk of developing cancer is unclear. Here we use a national claims database to show that sepsis survivors had a lower cumulative incidence of cancers than matched nonsevere infection survivors. We identify a chemokine network released from sepsis-trained resident macrophages that triggers tissue residency of T cells via CCR2 and CXCR6 stimulations as the immune mechanism responsible for this decreased risk of de novo tumor development after sepsis cure. While nonseptic inflammation does not provoke this network, laminarin injection could therapeutically reproduce the protective sepsis effect. This chemokine network and CXCR6 tissue-resident T cell accumulation were detected in humans with sepsis and were associated with prolonged survival in humans with cancer. These findings identify a therapeutically relevant antitumor consequence of sepsis-induced trained immunity.